<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03874481</url>
  </required_header>
  <id_info>
    <org_study_id>T2018-ZX026</org_study_id>
    <nct_id>NCT03874481</nct_id>
  </id_info>
  <brief_title>The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis</brief_title>
  <official_title>The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China National Center for Cardiovascular Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China National Center for Cardiovascular Diseases</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional and follow-up study. We analysis the relationship of sleep quality
      on coronary artery disease(CAD) and in stent restenosis(ISR). Further, we explore the
      mechanism of relationship between the sleep quality and CAD/ ISR by examining the biomarkers
      in the pathway of sleep-CAD/ISR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Coronary artery disease (CAD) is the leading cause of mortality in the world. The
      important treatment of CAD is Percutaneous coronary intervention(PCI). However,
      in-stent-restenosis(ISR) is the major issue in the PCI. The factors of ISR include gender,
      age, diabetes, lipid ,obesity and so on.Recently, studies showed that sleep duration and
      sleep quality have effect on all of factors and have relationship with coronary artery
      calcification. We like to explore the relationship between sleep quality and CAD/ISR.

      Aims:This is a cross-sectional and follow-up study. We analysis the relationship of sleep
      quality on coronary artery disease(CAD) and in stent restenosis(ISR). Further, we explore the
      mechanism of relationship between the sleep quality and CAD/ ISR by examining the biomarkers
      in the pathway of sleep-CAD/ISR.

      Methods: We include patients who were diagnosed as CAD by coronary arteriography. Sleep
      duration and quality were evaluated from sleep questionnaire. During the 6 months and
      9-12months, we follow up the patients who got PCI and get information of Major Adverse
      Cardiovascular Events (MACE) from follow-up questionnaire. On 9-12 months after PCI, coronary
      arteriography were produced in PCI patients. Biomarkers were tested during the follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>In-stent restenosis</measure>
    <time_frame>9-12 months from PCI</time_frame>
    <description>The rate of in stent restenosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>6months, 12months</time_frame>
    <description>The rate of cardiovascular(CV) death (death due to a cardiovascular cause), myocardial infarction (MI) or Severe Recurrent Ischemia requiring Urgent coronary artery Revascularization,Hospitalization for CV, Stroke, Death, Heart failure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">958</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>In-stent Restenosis</condition>
  <arm_group>
    <arm_group_label>PCI</arm_group_label>
    <description>Patients who had stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>follow up regularly for MACE</description>
    <arm_group_label>PCI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Coronary arter disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Coronary artery disease

          -  PCI patients in the follow-up

          -  written informed consent

        Exclusion Criteria:

          -  Heart failure; renal failure; secondary hypertension;valvular heart disease ;Cancer;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hongjian Wang, Dr</last_name>
    <phone>13910008985</phone>
    <email>wanghongjianfw@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hongjian Wang</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongjian Wang</last_name>
      <phone>13910008985</phone>
      <phone_ext>13910008985</phone_ext>
      <email>wanghongjianfw@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yin Dong</last_name>
      <phone>13552582795</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>November 20, 2018</study_first_submitted>
  <study_first_submitted_qc>March 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2019</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China National Center for Cardiovascular Diseases</investigator_affiliation>
    <investigator_full_name>Hongjian Wang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>sleep duration</keyword>
  <keyword>sleep quality</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>in stent restenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

